Xinyuan (Susie) Zhang, PhD

Daiichi Sankyo, Inc.

Xinyuan (Susie) Zhang, Ph.D., is a Director of Quantitative Clinical Pharmacology at Daiichi Sankyo, Inc. (DSI). Prior to joining DSI, she was a co-lead for the physiologically based pharmacokinetic (PBPK) program in the Division of Pharmacometrics (DPM),Office of Clinical Pharmacology (OCP), US Food and Drug Administration (US FDA), where she provided scientific oversight of PBPK review and research activities in OCP. Dr. Zhang has conducted clinical pharmacology reviews for numerous Investigational New Drug (IND) applications and New Drug Applications (NDAs). Prior to joining OCP, Dr. Zhang was a scientific lead for absorption modeling in the Office of Generic Drugs (OGD), US FDA, where she focused on applying PBPK absorption modeling and simulation to address scientific issues in generic drug product review and guidance development.  She received her Ph.D. from the University of Michigan, Ann Arbor.

Disclosure information not submitted.

Presentation(s):

• Practical Aspects of Using PBPK Modeling to Support Model-Informed Dosing in Pregnant Women and Children: A Hands-On Workshop for Non-Modelers

  Friday, September 16, 2022
  10:00 AM – 4:00 PM ET